Zum Inhalt springen
Sponsorship
Die MVF-Knowledge-HubsFrisch aus der Forschung. Täglich aktualisiert!

Suchen Sie in Hunderten nationaler und internationaler Datenbanken nach dem neuesten Studienwissen der angegebenen Themengebiete und/oder lassen Sie sich werktäglich per Newsletter informieren. Die Newsfeeds werden auf deutsch übersetzt and nach Übertragbarkeit auf das deutsche Gesundheits-/Versorgungssystem ausgewählt:

Zu den Knowledge-Hubs

Analgesics in the treatment of elderly patients

In 2010, more than 20 million people insured by statutory health insurance were treated with prescription pain medications on an outpatient basis, around half of whom were older than 60 years. These analgesics can be classified according to the WHO grading scheme. Non-opioid analgesics, low-potency opioid analgesics in combination with non-opioids and strong opioids in combinations form the three levels of the scheme. As an analysis by INSIGHT Health shows, there are age- and gender-specific abnormalities within the statutory health insurance system with regard to the extent of medication provision for pain patients. The use of pain medications that are on the Priscus list is also not uncommon in older people.

Read more
First publication date: 25.09.2012

Additional Information

Plain Text

> Pain is one of the most important complaints in the population. When determining prevalence, numerous epidemiological studies are based on the underlying clinical pictures of back pain, headaches and others. However, there are hardly any studies that examine the clinical picture of pain as a whole.
In order to ensure treatment prevalence, an approach is chosen that is based on the reality of care with pain therapeutics. The patient is not questioned about his or her specific pain at a specific point in time, but the therapy process is chosen as the basis for depicting the prevalence statistics. One starting point here is the analysis of anonymized outpatient GKV prescription information.

....

Do you want to leave us already?

Subscribe to our newsletter quickly. Then you can be sure that you won't miss anything.